All public logs
Jump to navigation
Jump to search
Combined display of all available logs of HemOnc.org - A Hematology Oncology Wiki. You can narrow down the view by selecting a log type, the username (case-sensitive), or the affected page (also case-sensitive).
(newest | oldest) View (newer 100 | older 100) (20 | 50 | 100 | 250 | 500)- 20:52, 3 November 2023 Jwarner talk contribs created page Acute lymphoblastic leukemia, infant - historical (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:49, 3 November 2023 Jwarner talk contribs created page Category:Acute lymphoblastic leukemia, infant regimens (Created page with "Category:Acute lymphoblastic leukemia regimens")
- 20:48, 3 November 2023 Jwarner talk contribs created page Acute lymphoblastic leukemia, infant (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 00:37, 1 November 2023 Jwarner talk contribs created page Merkel cell carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 10:59, 31 October 2023 Jwarner talk contribs created page Motixafortide (Aphexda) (Created page with "cyclic-peptide CXCR4 inhibitor Category:Drugs Category:CXCR4 inhibitor Category:FDA approved in 2023 Category:Stub")
- 23:34, 28 October 2023 Jwarner talk contribs created page Category:Anti-CLDN18.2 antibodies (Created page with "Category:Antineoplastic monoclonal antibodies")
- 23:33, 28 October 2023 Jwarner talk contribs created page Category:Gastric cancer medications (investigational) (Created page with "Category:Gastric cancer medications")
- 23:33, 28 October 2023 Jwarner talk contribs created page Zolbetuximab (IMAB-362) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/zolbetuximab NCI Drug Dictionary]: A chimeric immunoglobulin G1 (IgG1) monoc...")
- 21:53, 28 October 2023 Jwarner talk contribs created page Fitusiran (ALN-AT3SC) (Created page with "==Mechanism of action== siRNA therapeutic, targets antithrombin ==Preliminary data== ===Inherited coagulopathy=== #'''ATLAS-A/B:''' Srivastava A, Rangarajan S, Kavakli K,...")
- 21:34, 28 October 2023 Jwarner talk contribs created page Hepatic veno-occlusive disease - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 21:31, 28 October 2023 Jwarner talk contribs created page Category:Hepatic veno-occlusive disease regimens (Created page with "Regimens with some demonstrated degree of efficacy in the treatment of hepatic veno-occlusive disease.")
- 21:30, 28 October 2023 Jwarner talk contribs created page Hepatic veno-occlusive disease (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 00:45, 26 October 2023 Jwarner talk contribs created page ASCO guidelines (Created page with "This page will be a gathering place for the American Society of Clinical Oncology (ASCO) guidelines that do not clearly fit under a disease-specific page. '''Given the rapid...")
- 00:51, 25 October 2023 Jwarner talk contribs created page Myelodysplastic syndrome, IDH-mutated (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 23:32, 24 October 2023 Jwarner talk contribs created page Category:KFDA approved in 2021 (Created page with "Category:KFDA approved drugs")
- 23:31, 24 October 2023 Jwarner talk contribs created page Lazertinib (Leclaza) (Created page with "==General information== Class/mechanism from the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/lazertinib NCI Drug Dictionary]: An orally available third-g...")
- 22:44, 15 October 2023 Jwarner talk contribs created page ESMO guidelines (Created page with "This page will be a gathering place for ESMO guidelines that do not clearly fit under a disease-specific page. =Fertility & Pregnancy= *'''2013:''' Peccatori et al. [https://...")
- 20:38, 14 October 2023 Jwarner talk contribs created page Tenosynovial giant cell tumor - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 20:34, 14 October 2023 Jwarner talk contribs created page Subependymal giant cell astrocytoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:08, 14 October 2023 Jwarner talk contribs created page Myelodysplastic syndrome - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 14:42, 11 October 2023 Jwarner talk contribs created page PJP Prophylaxis (Created page with "The purpose of this page is to list the various types of PJP prophylaxis in common usage. ==Guidelines== ==Prophylaxis== ===Trimethoprim-Sulfamethoxazole (Bactrim DS)|Tri...")
- 20:55, 3 October 2023 Jwarner talk contribs created page Category:Anti-Factor IXa/Factor Xa bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 20:55, 3 October 2023 Jwarner talk contribs created page Category:Anti-EGFR/HGFR bispecific antibodies (Created page with "Category:Bispecific antibody medications")
- 20:50, 3 October 2023 Jwarner talk contribs moved page Category:Anti-GPRC5D bispecific T-cell engager antibodies to Category:Anti-GPRC5D/CD3 bispecific antibodies
- 20:47, 3 October 2023 Jwarner talk contribs moved page Category:Anti-EpCAM bispecific T-cell engager antibodies to Category:Anti-EpCAM/CD3 bispecific antibodies
- 20:45, 3 October 2023 Jwarner talk contribs moved page Category:Anti-CD33 bispecific T-cell engager antibodies to Category:Anti-CD33/CD3 bispecific antibodies
- 20:45, 3 October 2023 Jwarner talk contribs moved page Category:Anti-CD19 bispecific T-cell engager antibodies to Category:Anti-CD19/CD3 bispecific antibodies
- 20:43, 3 October 2023 Jwarner talk contribs moved page Category:Anti-CD20 bispecific T-cell engager antibodies to Category:Anti-CD20/CD3 bispecific antibodies
- 20:40, 3 October 2023 Jwarner talk contribs moved page Category:Anti-BCMA bispecific T-cell engager antibodies to Category:Anti-BCMA/CD3 bispecific antibodies
- 19:56, 3 October 2023 Jwarner talk contribs created page Category:Small bowel adenocarcinoma medications (Created page with "Category:Gastrointestinal oncology medications")
- 22:20, 1 October 2023 Jwarner talk contribs created page Category:PMDA approved in 1981 (Created page with "Category:PMDA approved drugs")
- 22:15, 1 October 2023 Jwarner talk contribs created page Category:Loop diuretics (Created page with "Category:Diuretics")
- 21:45, 1 October 2023 Jwarner talk contribs created page Category:Light-chain (AL) amyloidosis medications (investigational) (Created page with "Category:Light-chain (AL) amyloidosis medications")
- 15:22, 29 September 2023 Jwarner talk contribs moved page Folinic acid (Leucovorin) to Leucovorin (Folinic acid) (Alignment with INN)
- 20:13, 26 September 2023 Jwarner talk contribs created page Germ cell tumor (Created page with "At this point we do not have a dedicated page for germ cell tumors. More information about this broad class of tumors can be found [https://en.wikipedia.org/wiki/Germ_cell_tum...")
- 15:22, 23 September 2023 Jwarner talk contribs created page Category:Malignant neoplasm (Created page with "Category:Condition")
- 14:30, 23 September 2023 Jwarner talk contribs created page Category:TGF-beta inhibitors (Created page with "Category:Erythrocyte growth factors")
- 14:24, 23 September 2023 Jwarner talk contribs created page Category:Urate oxidase (Created page with "Category:Uric acid lowering agents")
- 12:16, 23 September 2023 Jwarner talk contribs created page Category:Synthetic muramyl dipeptides (Created page with "Category:Immunotherapeutic")
- 11:51, 23 September 2023 Jwarner talk contribs created page Category:GnRH analogs (Created page with "Category:Endocrine therapeutic")
- 11:27, 23 September 2023 Jwarner talk contribs created page Category:JAK3 inhibitors (Created page with "Category:JAK inhibitors")
- 11:25, 23 September 2023 Jwarner talk contribs created page Category:JAK1 inhibitors (Created page with "Category:JAK inhibitors")
- 11:24, 23 September 2023 Jwarner talk contribs created page Category:JAK2 inhibitors (Created page with "Category:JAK inhibitors")
- 00:29, 23 September 2023 Jwarner talk contribs created page Category:Anti-IL-2R immunotoxins (Created page with "Category:Immunotoxin")
- 00:12, 23 September 2023 Jwarner talk contribs created page Category:Topoisomerase II inhibitors (Created page with "Category:Topoisomerase inhibitors")
- 23:38, 22 September 2023 Jwarner talk contribs moved page Category:SMO or PTCH-1 (Hedgehog) medications to Category:Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog) medications
- 23:37, 22 September 2023 Jwarner talk contribs moved page SMO or PTCH-1 (Hedgehog) to Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog)
- 23:37, 22 September 2023 Jwarner talk contribs moved page Category:SMO or PTCH-1 (Hedgehog) regimens to Category:Malignant solid neoplasm, SMO-mutated or PTCH-1-mutated (Hedgehog) regimens
- 23:33, 22 September 2023 Jwarner talk contribs moved page Category:TMB-H medications to Category:Malignant solid neoplasm, TMB-H medications
- 23:32, 22 September 2023 Jwarner talk contribs moved page TMB-H to Malignant solid neoplasm, TMB-H
- 23:32, 22 September 2023 Jwarner talk contribs moved page Category:TMB-H regimens to Category:Malignant solid neoplasm, TMB-H regimens
- 23:31, 22 September 2023 Jwarner talk contribs moved page Category:RET medications to Category:Malignant solid neoplasm, RET-mutated medications
- 23:30, 22 September 2023 Jwarner talk contribs moved page RET to Malignant solid neoplasm, RET-mutated
- 23:29, 22 September 2023 Jwarner talk contribs moved page Category:RET regimens to Category:Malignant solid neoplasm, RET-mutated regimens
- 23:37, 21 September 2023 Jwarner talk contribs created page Category:Malignant solid neoplasm, NTRK-mutated medications (Created page with "Medications with some degree of efficacy in the treatment of NTRK-mutated solid tumors, regardless of anatomic site of origin. Ca...")
- 23:33, 21 September 2023 Jwarner talk contribs moved page Category:NTRK regimens to Category:Malignant solid neoplasm, NTRK-mutated regimens
- 23:32, 21 September 2023 Jwarner talk contribs moved page NTRK to Malignant solid neoplasm, NTRK-mutated
- 23:24, 21 September 2023 Jwarner talk contribs moved page Category:MSI-H or dMMR medications to Category:Malignant solid neoplasm, MSI-H or dMMR medications
- 23:23, 21 September 2023 Jwarner talk contribs moved page Category:MSI-H or dMMR regimens to Category:Malignant solid neoplasm, MSI-H or dMMR regimens
- 23:22, 21 September 2023 Jwarner talk contribs moved page MSI-H or dMMR to Malignant solid neoplasm, MSI-H or dMMR
- 21:48, 21 September 2023 Jwarner talk contribs moved page ERBB3 (HER3) to Malignant solid neoplasm, ERBB3-mutated
- 21:48, 21 September 2023 Jwarner talk contribs moved page Category:ERBB3 (HER3) regimens to Category:Malignant solid neoplasm, ERBB3-mutated regimens
- 21:07, 21 September 2023 Jwarner talk contribs moved page Category:ERBB3 (HER3) medications to Category:Malignant solid neoplasm, ERBB3-mutated medications
- 21:07, 21 September 2023 Jwarner talk contribs moved page Category:ERBB2 (HER2) medications to Category:Malignant solid neoplasm, ERBB2-mutated medications
- 21:05, 21 September 2023 Jwarner talk contribs moved page Category:ERBB2 (HER2) regimens to Category:Malignant solid neoplasm, ERBB2-mutated regimens
- 21:04, 21 September 2023 Jwarner talk contribs moved page ERBB2 (HER2) to Malignant solid neoplasm, ERBB2-mutated
- 16:27, 21 September 2023 Jwarner talk contribs moved page Category:Solid malignant neoplasm, EGFR-mutated regimens to Category:Malignant solid neoplasm, EGFR-mutated regimens
- 16:27, 21 September 2023 Jwarner talk contribs moved page Solid malignant neoplasm, EGFR-mutated to Malignant solid neoplasm, EGFR-mutated
- 16:26, 21 September 2023 Jwarner talk contribs moved page Category:Solid malignant neoplasm, EGFR-mutated medications to Category:Malignant solid neoplasm, EGFR-mutated medications
- 16:07, 21 September 2023 Jwarner talk contribs moved page Category:EGFR medications to Category:Solid malignant neoplasm, EGFR-mutated medications
- 16:04, 21 September 2023 Jwarner talk contribs moved page Category:EGFR regimens to Category:Solid malignant neoplasm, EGFR-mutated regimens
- 16:03, 21 September 2023 Jwarner talk contribs moved page EGFR to Solid malignant neoplasm, EGFR-mutated
- 15:15, 21 September 2023 Jwarner talk contribs moved page Category:BRAF medications to Category:Malignant solid neoplasm, BRAF-mutated medications
- 15:13, 21 September 2023 Jwarner talk contribs moved page Category:BRAF regimens to Category:Malignant solid neoplasm, BRAF-mutated regimens
- 15:12, 21 September 2023 Jwarner talk contribs moved page BRAF to Malignant solid neoplasm, BRAF-mutated
- 23:43, 18 September 2023 Jwarner talk contribs created page Category:Anti-dabigatran antibody fragments (Created page with "Category:Anticoagulant reversal agents")
- 23:43, 18 September 2023 Jwarner talk contribs created page Category:Anticoagulant reversal agents (Created page with "Category:Classical hematology medications")
- 23:43, 18 September 2023 Jwarner talk contribs created page Category:Heparin antagonist (Created page with "Category:Anticoagulant reversal agents")
- 23:30, 18 September 2023 Jwarner talk contribs created page Category:Small bowel carcinoma medications (Created page with "Category:Gastrointestinal oncology medications")
- 23:28, 18 September 2023 Jwarner talk contribs created page Category:Folic acid analog (Created page with "Category:Potentiating agents Category:Chemotherapy protective agents")
- 23:27, 18 September 2023 Jwarner talk contribs created page Category:Potentiating agents (Created page with "A category of drugs that potentiate the effect of another drug or localized intervention. Category:Drugs")
- 15:20, 15 September 2023 Jwarner talk contribs created page Category:Anti-CD7 CAR T-cells (Created page with "Category:Chimeric antigen receptor T-cells")
- 15:20, 15 September 2023 Jwarner talk contribs created page Category:T-cell acute lymphoblastic leukemia medications (investigational) (Created page with "Category:T-cell acute lymphoblastic leukemia medications")
- 15:19, 15 September 2023 Jwarner talk contribs created page BE-CAR7 (Created page with "==Mechanism of action== Base-edited ("off the shelf") CAR T-cells directed against CD7 ==Preliminary data== #Chiesa R, Georgiadis C, Syed F, Zhan H, Etuk A, Gkazi SA, Preece...")
- 14:55, 15 September 2023 Jwarner talk contribs created page Category:Cereblon E3 ubiquitin ligase modulators (Created page with "Category:Enzyme inhibitors")
- 14:54, 15 September 2023 Jwarner talk contribs created page Mezigdomide (BMS-986348) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/mezigdomide NCI Drug Dictionary]: A modulator of the E3 ubiquitin ligase com...")
- 16:44, 13 September 2023 Jwarner talk contribs created page Category:Topoisomerase I inhibitors (Created page with "Category:Topoisomerase inhibitors")
- 16:41, 13 September 2023 Jwarner talk contribs created page Category:Alkyl sulfonates (Created page with "Category:Alkylating agents")
- 19:23, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinoma medications (investigational) (Created page with "Category:Urothelial carcinoma medications")
- 13:44, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinomas (Created page with "Category:Genitourinary cancers")
- 12:35, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinoma medications (Created page with "Medications which have been shown to have some degree of efficacy in the treatment of urothelial carcinoma. Category:Genitourinary oncology medications")
- 12:21, 9 September 2023 Jwarner talk contribs created page Category:Urothelial carcinoma regimens (Created page with "Category:Genitourinary (GU) oncology regimens")
- 12:16, 9 September 2023 Jwarner talk contribs created page Urothelial carcinoma - null regimens (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:04, 9 September 2023 Jwarner talk contribs moved page Bladder cancer - historical to Urothelial carcinoma - historical
- 11:53, 9 September 2023 Jwarner talk contribs moved page Bladder cancer to Urothelial carcinoma
- 16:31, 7 September 2023 Jwarner talk contribs moved page Olverembatinib (HQP1351) to Olverembatinib (HQP-1351) (naming standardization)
- 01:25, 7 September 2023 Jwarner talk contribs created page How I Treat (Created page with "The "How I Treat" series has been published by ''Blood'' for several decades and covers a wide variety of topics in malignant and classical hematology. While these articles ar...")
- 20:59, 5 September 2023 Jwarner talk contribs created page Category:Small bowel carcinoma regimens (Created page with "Category:Gastrointestinal (GI) oncology regimens")
- 20:58, 5 September 2023 Jwarner talk contribs created page Small bowel adenocarcinoma (Created page with "<span id="BackToTop"></span> <div class="noprint" style="background-color:LightGray; position:fixed; bottom:2%; right:0.25%; padding-left:5px; padding-right:5px; margin: 15px;...")
- 12:09, 4 September 2023 Jwarner talk contribs moved page Eculizumab (Epysqli) to Eculizumab-epys (Epysqli) (Biosimilar naming convention)